From: Perseverant, non-indicated treatment of obese patients for obstructive lung disease
Total | Asthma | COPD | Mixed | Normal | Restriction | |
---|---|---|---|---|---|---|
FEV1% | 66.6 ± 1.4 | 59.9 ± 6.4 | 55.2 ± 2.5 | 50.1 ± 5.7 | 92.8 ± 1.6 | 66.6 ± 2.8 |
FVC% | 65.9 ± 1.3 | 74.3 ± 5.3 | 72.8 ± 2.6 | 61.5 ± 7.6 | 92.5 ± 1.6 | 65.9 ± 2.7 |
FEV1/FVC% | 77.8 ± 1.1 | 64 ± 5.5 | 58.9 ± 1.9 | 64.8 ± 3.5 | 81.5 ± 0.9 | 77.8 ± 2.4 |
TLC%* | 82.7 ± 3.7 | 97.2 ± 6.4 | 101.5 ± 7.6 | 66.6 ± 4.6 | 100.2 ± 13.4 | 69.1 ± 1.4 |